United States:
Washington Stirs As India Undermines Patents
07 November 2013
WilmerHale
To print this article, all you need is to be registered or login on Mondaq.com.
India's approach to pharmaceutical patents is gathering
increased attention in Washington, with recent high-level pressure
on the Indian government to do more to protect intellectual
property.
Originally published in the October 23, 2013 edition of The
Daily Journal.
Click here to read the full text of this
article.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.
